Decheng Capital’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMGN
Decheng Capital's IMGN Position: Q1 2024 in Review
Decheng Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 659,928 shares — an estimated $19.6M sold.
Decheng Capital first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $19.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Decheng Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Decheng Capital sold 659,928 Immunogen Inc shares in Q1 2024, an estimated $19.6M.
- Decheng Capital first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
- Decheng Capital's Immunogen Inc position peaked at $19.6M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Decheng Capital's 13F filing for Q1 2024, filed 14 May 2024.